Teva Pharma Files 8-K on Operations & Financials
Ticker: TEVJF · Form: 8-K · Filed: Jul 30, 2025 · CIK: 818686
| Field | Detail |
|---|---|
| Company | Teva Pharmaceutical Industries Ltd (TEVJF) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Teva dropped an 8-K detailing its financials and operations as of July 30, 2025.
AI Summary
Teva Pharmaceutical Industries Ltd. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to its business operations. The company is incorporated in Israel and its principal executive offices are located in Tel Aviv.
Why It Matters
This filing provides investors with updated information on Teva's financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing providing standard financial and operational updates, not indicating any immediate or significant new risks.
Key Players & Entities
- TEVA PHARMACEUTICAL INDUSTRIES LTD (company) — Registrant
- July 30, 2025 (date) — Date of Report
- Israel (location) — Jurisdiction of Incorporation
- Tel Aviv (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these are not provided in the header information.
When was this 8-K filed?
This 8-K was filed on July 30, 2025.
Where are Teva Pharmaceutical Industries Ltd.'s principal executive offices located?
The principal executive offices are located at 124 Dvora Hanevi'a Street, Tel Aviv, Israel.
What is the standard industrial classification for Teva Pharmaceutical Industries Ltd.?
The standard industrial classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the Commission File Number for Teva Pharmaceutical Industries Ltd.?
The Commission File Number is 001-16174.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF).